(Q36158031)

12 August 2017

1 reference

title

Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation (English)

1 reference

12 August 2017

Hylton V Joffe

1

1 reference

12 August 2017

Gail K Adler

series ordinal

2

1 reference

12 August 2017

language of work or name

1 reference

1 January 2005

1 reference

12 August 2017

published in

Heart Failure Reviews

1 reference

12 August 2017

volume

10

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

31-37

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-005-2346-0

12 August 2017

exact match

0 references

cites work

Aldosterone induces a vascular inflammatory phenotype in the rat heart

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2346-0

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2346-0

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2346-0

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2346-0

Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2346-0

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2346-0

Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2346-0

Endothelial function. From vascular biology to clinical applications

21 January 2018

1 reference

12 December 2020

50th anniversary of aldosterone

1 reference

12 December 2020

Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole

1 reference

12 December 2020

Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production

1 reference

12 December 2020

Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.

1 reference

12 December 2020

Albuminuria in untreated patients with primary aldosteronism or essential hypertension

1 reference

12 December 2020

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

1 reference

12 December 2020

The general adaptation syndrome and the diseases of adaptation

1 reference

12 December 2020

Myocardial fibrosis: functional significance and regulatory factors

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart

1 reference

12 December 2020

Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension

1 reference

12 December 2020

Mineralocorticoid receptor antagonism in experimental atherosclerosis

1 reference

12 December 2020

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

12 December 2020

Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice

1 reference

12 December 2020

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

1 reference

12 December 2020

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

1 reference

12 December 2020

Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease

1 reference

12 December 2020

Spironolactone improves angiotensin-induced vascular changes and oxidative stress

1 reference

12 December 2020

Cardiovascular complications in patients with primary aldosteronism

1 reference

12 December 2020

Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone

1 reference

12 December 2020

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

12 December 2020

Determinants of cardiac fibrosis in experimental hypermineralocorticoid states

1 reference

12 December 2020

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

1 reference

12 December 2020

Aldosterone: a mediator of myocardial necrosis and renal arteriopathy

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis

1 reference

12 December 2020

Angiotensin II as a cardiovascular risk factor

1 reference

12 December 2020

The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

1 reference

12 December 2020

Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury

1 reference

12 December 2020

10.1007/S10741-005-2346-0

Identifiers

DOI

1 reference

12 August 2017

1 reference